MALT (psychedelic drug)

MALT

Names
Systematic IUPAC name N-[2-(1H-Indol-3-yl)ethyl]-N-methylprop-2-en-1-amine
Other names N,N-Methylallyltyptamine
Identifiers
3D model (JSmol)	Interactive image
PubChem CID	155907915
UNII	R3PSM6BEG8
InChI InChI=1S/C14H18N2/c1-3-9-16(2)10-8-12-11-15-14-7-5-4-6-13(12)14/h3-7,11,15H,1,8-10H2,2H3 Key: GXCLVBGFBYZDAG-UHFFFAOYSA-N
SMILES CN(CCC1=CNC2=CC=CC=C21)CC=C
Pharmacology
Routes of administration	Oral, insufflated, rectal, smoked, IM, IV[citation needed]
Legal status	UK: Class A US: Analogue to a Schedule I/II drug (possibly)
Properties
Chemical formula	C14H18N2
Molar mass	214.312 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

MALT crystals

MALT (N-methyl-N-allyltryptamine or N,N-methylallyltryptamine) is a lesser-known drug from the tryptamine family. It is a novel compound with very little history of human use. It is closely related to methylpropyltryptamine (MPT), as well as N-methyltryptamine. It has been sold online as a designer drug. Very little information on the pharmacology or toxicity of MALT is available.

Legality[]

MALT is not explicitly scheduled in any countries; however, it could be considered a psychoactive substance under the UK Psychoactive Substances Act, which requires the prosecutor to prove that the substance is psychoactive in order for a person to be charged with an offense.^[1]

It could also be considered a structural analog of a scheduled substance under the US Federal Analogue Act due to its similarity to scheduled tryptamines.

See also[]

• 5-Methoxy-N,N-Methylallyltryptamine (5-MeO-MALT)
• N,N-Diallyltryptamine (DALT)
• Methylpropyltryptamine (MPT)

Further reading[]

• Chadeayne, Andrew R.; Pham, Duyen N. K.; Golen, James A.; Manke, David R. (2020). "DMT analogues: N-ethyl-N-propyltryptamine and N-allyl-N-methytryptamine as their hydrofumarate salts". Acta Crystallographica Section E. 76 (8): 1201–1205. doi:10.1107/S2056989020008683. PMC 7405555. PMID 32843999.
• Brandt, S. D.; Freeman, S.; Fleet, I. A.; McGagh, P.; Alder, J. F. (2004). "Analytical chemistry of synthetic routes to psychoactive tryptamines". The Analyst. 129 (11): 1047–1057. doi:10.1039/b407239c. PMID 15508033.

References[]